Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
The Dales Report

Stifel Initiates Coverage On Awakn Life Sciences With A Speculative Buy, $8 Target Price Target

Awakn Life Sciences (OTC:AWKNF) is in the news after a respected analyst has upgraded the stock.  Awakn is a publicly traded company which trades on the over-the-counter market with the symbol of AWKNF.  Let’s take a look at the stock’s upgrade and long-term potential in the context of psychedelics investing.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.